|
HIV
|
|||||||||||||||||
|
Path
|
· Env gene
· Gp120: attach HIV to cells
· Gp40: Fusion + entry into cells
· gag gene
· p24: capsid
· p17: viral matrix protein
· pol gene:
· Reverse transcriptase
|
||||||||||||||||
|
Dx
|
· Fourth-generation combination HIV-1/2 immunoassay
· best initial test
· detects both
o HIV-1 and HIV-2 antibodies
o HIV p24 antigen
· interpretation
o if negative → ø
o if positive: perform an HIV-1/HIV-2 antibody differentiation immunoassay → Confirm Dx
o if the differentiation immunoassay is negative or indeterminate → perform a viral load
· CD4+ T-cell count and percentage
· HIV genotyping
|
||||||||||||||||
|
Tx
|
· 2 NRTI + 1 other (integrase inhibitor)
· The MCC of tx failure is nonadherence
· Pregnancy and HIV:
· Tx the same except ⤵️
· Avoid: dolutegravir – elvitegravir – tenofovir alafenamide
· If viral load >1000 → C-Section + IV Zidovudine
· AVOID BREASTFEEDING ❌
· For the baby:
· If viral load <1000 → Zidovudine for 4-6 weeks
· If viral load >1000 → zidovudine, lamivudine, and nevirapine in the infant for 6 weeks
|
||||||||||||||||
|
PPx
|
· Post-exposure prophylaxis
· first-line treatment given immediately after HIV exposure (such as in health care personnel)
· initiate within 72 hours
· drug regimen: tenofovir, emtricitabine, and raltegravir
· Pre-exposure prophylaxis
· to prevent HIV infection in high-risk patients
· tenofovir and emtricitabine
· HIV is an indication for obtaining the following vaccines:
· pneumococcal
· hepatitis B (if not already immune)
· meningococcal
|
||||||||||||||||
|
Common causes of diarrhea in AIDS
|
||
|
CD4 count
|
Sx
|
|
|
Cryptosporidium
|
< 180
|
· Severe watery diarrhea
· Low-grade fever
· Weight loss
|
|
Mycobacterium avum complex
|
< 50
|
· Watery diarrhea
· High fever >39
· Weight loss
|
|
CMV
|
< 50
|
· Frequent small diarrhea
· Hematochezia
· Abdominal pain
· Low-grade fever
· Weight loss
|
|
Opportunistic organisms in HIV
|
||
|
PCP
|
CD4+ < 200
Oral candidiasis
|
TMP-SMX
|
|
Toxo
|
CD4+ <100
+Toxoplasma IgG Ab
|
TMP-SMX
|
|
MAC
|
CD4+ < 50
|
Azithro
|
|
Histoplasma
|
CD4+ <150
Endemic area / Caves
Ohio+ Mississippi river
|
Itraconazole
|
|
Pneumocystis Jirovicii
|
|
|
Clx
|
· Indolent (HIV) or acute respiratory failure (immunocompromised)
· Fever, dry cough, ↓ oxygen levels (HYPOXIA)
|
|
Dx
|
· ↑ LDH level
· CXR: ⓑ Diffuse reticular infiltrates
· Induced sputum or BAL (stain)
|
|
Tx
|
· TMP-SMX
· Prednisone if ⤵️ O2 levels
|
|
PPx
|
· TMP-SMX (CD4 <200)
|
|
CMV Pneumonitis
|
|
CMV is a common opportunistic infection that may cause pneumonitis.
|
|
Marked by:
– dyspnea,
– nonproductive cough,
– low-grade fever,
– diffuse ground-glass opacities on CT scan.
|
|
Disseminated Mycobacterium avium complex (MAC)
|
|
|
Sx
|
Nonspecific sx (eg, fever, cough, abdominal pain, diarrhea, night sweats, weight loss)
+ splenomegaly
+ ALP
in pt w/ CD4 cell count <50/mm3.
|
|
Dx
|
Blood cultures (or lymph node or bone marrow biopsy)
|
|
PPx
|
CD4 cell count <50/mm3 should receive azithromycin prophylaxis against MAC.
|
|
Tx
|
1˚ clarithromycin or azithromycin.
|
|
DDx
|
CMV: check lgG/lgM
TB: check hx, cxr, skin test
|
|
HIV drug
|
SE
|
|
NRTI
|
· BM suppression (can be reversed with G-CSF and EPO),
· peripheral neuropathy,
· lactic acidosis (nucleosides),
· anemia (ZDV),
· pancreatitis (didanosine).
· Abacavir contraindicated if patient has HLA-B*5701 mutation due to risk of hypersensitivity.
|
|
NNRTI
|
· Rash and hepatotoxicity are common to all NNRTIs.
· Vivid dreams and CNS symptoms are common with efavirenz.
· Delavirdine and efavirenz are contraindicated in pregnancy.
|
|
Protease inhibitor
|
· Hyperglycemia,
· GI intolerance (nausea, diarrhea),
· lipodystrophy (Cushing-like syndrome).
· Nephropathy, hematuria, thrombocytopenia (indinavir).
· Rifampin (potent CYP/UGT inducer) reduces protease inhibitor concentrations; use rifabutin instead.
|
|
Integrase inhibitor
|
⤴️ CK
|
